National repository for lines of embryonic and tissue origin. Includes FAQ, instructions for deposition and requesting batches, with contacts in London.

Offers ISO 17025 compliant storage of stem cells derived from the bone marrow, and associated testing in Harrow, England.

Developing somatic transplantation technology for diabetes, neuronal degeneration and therapy for brain damage including stroke, Parkinson's disease, Alzheimer's and Huntington's disease. Overview of company in Guildford, England.

Research and development of retrodifferentiation technology, used to create stem cells from mature adult cells. Includes technological and corporate overview, with FAQ and contacts in London, UK.

Research on production of undifferentiated ES and foetal cell lines to GMP grade, with feeder-free, chemically defined culture conditions. Includes introduction, details of meetings and contacts at the University of Sheffield, England.

Promoting bone marrow stromal cells as alternative to ES, for differentiation into hepatocytes and neural cells. Contacts in Kharkov, Ukraine.

A Canadian association that brings together scientists, clinicians, and ethicists to investigate the therapeutic potential of stem cells. Includes articles about research in field being currently conducted.

Current U.S. patents on embrionic stem cells; focused identification of Geron's related patents.

Aims to build integrated national research to deliver technologies and therapies of embryonic and adult origin. Includes biological and synthetic matrices, immune modulation and therapeutic programs at Monash University, Clayton, Victoria.

Research on the isolation and characterization of muscle-derived stem cells and their use in cellular therapy of Duchenne muscular dystrophy, injury repair and limb lengthening at the University of Pittsburgh School of Medicine, Pennsylvania.